Publications by authors named "Jiangmin Su"
Article Synopsis
- Xiebai San (XBS) is a traditional Chinese medicine used for treating pneumonia-related diseases, but its specific anti-pneumonia properties and mechanisms have not been fully understood until now.* -
- The study aimed to investigate the active components and mechanisms of XBS using various methods in zebrafish and RAW264.7 cells, including chemical analysis and molecular docking to identify key targets and anti-inflammatory effects.* -
- Results showed that XBS effectively reduced inflammation by decreasing neutrophil aggregation and nitric oxide release, while also suppressing inflammatory cytokines involved in key signaling pathways, indicating its potential as an effective treatment for pneumonia.*
Background: Acute lung injury (ALI) often leads to serious respiratory diseases with high incidence rates and mortality. For centuries, Xiebai San (XBS) has been a classical traditional Chinese medicine (TCM) about respiratory illness such as pneumonia in children. However, the related mechanism of XBS against ALI remains indistinct.
View Article and Find Full Text PDF[Improvement of high-quality evaluation criteria of Chinese patent medicines based on whole process control].
Zhongguo Zhong Yao Za Zhi
March 2023
Chinese patent medicines(CPMs) are unique therapeutic drugs in China. Establishing and improving the evaluation criteria is an important measure to promote the high-quality development of CPMs. Based on the "evaluation criteria of high-grade CPMs with quality as the core index" established by our group in 2018, the "high-quality evaluation criteria for CPMs based on whole process control" was proposed in the present study in 2022.
View Article and Find Full Text PDF